These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9479574)

  • 21. Pathogenic anti-DNA autoantibodies and pathogenic autoantibody-inducing T cells.
    Datta SK; Rajagopalan S; O'Keefe TL; Ghatak S; Imanishi-Kari T
    Immunol Ser; 1991; 55():133-53. PubMed ID: 1835406
    [No Abstract]   [Full Text] [Related]  

  • 22. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis.
    Mohan C; Shi Y; Laman JD; Datta SK
    J Immunol; 1995 Feb; 154(3):1470-80. PubMed ID: 7529804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lupus nephritis: role of antinucleosome autoantibodies.
    van der Vlag J; Berden JH
    Semin Nephrol; 2011 Jul; 31(4):376-89. PubMed ID: 21839371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cell receptor V beta genes expressed by IgG anti-DNA autoantibody-inducing T cells in lupus nephritis: forbidden receptors and double-negative T cells.
    Adams S; Zordan T; Sainis K; Datta S
    Eur J Immunol; 1990 Jul; 20(7):1435-43. PubMed ID: 2143726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
    Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
    Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Terminal deoxynucleotidyl transferase deficiency reduces the incidence of autoimmune nephritis in (New Zealand Black x New Zealand White)F1 mice.
    Conde C; Weller S; Gilfillan S; Marcellin L; Martin T; Pasquali JL
    J Immunol; 1998 Dec; 161(12):7023-30. PubMed ID: 9862739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms involved in the p62-73 idiopeptide-modulated delay of lupus nephritis in SNF(1) mice.
    Nyland JF; Stoll ML; Jiang F; Feng F; Gavalchin J
    Lupus; 2012 Dec; 21(14):1552-64. PubMed ID: 23015610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunopathogenesis of lupus nephritis: new insights from experimental models.
    Izui S
    Nihon Jinzo Gakkai Shi; 1995 Nov; 37(11):610-5. PubMed ID: 8583696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental models of lupus nephritis.
    Grande JP
    Contrib Nephrol; 2011; 169():183-197. PubMed ID: 21252519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathology of lupus nephritis.
    Giannakakis K; Faraggiana T
    Clin Rev Allergy Immunol; 2011 Jun; 40(3):170-80. PubMed ID: 20514528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus.
    Desai-Mehta A; Mao C; Rajagopalan S; Robinson T; Datta SK
    J Clin Invest; 1995 Feb; 95(2):531-41. PubMed ID: 7860735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Yaa gene-mediated acceleration of murine lupus: Yaa- T cells from non-autoimmune mice collaborate with Yaa+ B cells to produce lupus autoantibodies in vivo.
    Fossati L; Sobel ES; Iwamoto M; Cohen PL; Eisenberg RA; Izui S
    Eur J Immunol; 1995 Dec; 25(12):3412-7. PubMed ID: 8566031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on the cellular and molecular aspects of lupus nephritis.
    Frangou E; Georgakis S; Bertsias G
    Clin Immunol; 2020 Jul; 216():108445. PubMed ID: 32344016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial.
    Sfikakis PP; Boletis JN; Lionaki S; Vigklis V; Fragiadaki KG; Iniotaki A; Moutsopoulos HM
    Arthritis Rheum; 2005 Feb; 52(2):501-13. PubMed ID: 15693003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel pseudovirus encoding Diphtheriatoxin A fragment eliminates autoantibody-producing B cells and inhibits lupus in the BWF1 mouse model.
    Tan H; Yang X; Cui S; Yang Z
    Immunol Lett; 2009 Sep; 126(1-2):43-7. PubMed ID: 19660498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis.
    Shivakumar S; Tsokos GC; Datta SK
    J Immunol; 1989 Jul; 143(1):103-12. PubMed ID: 2525144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lupus nephritis: update on pathogenesis and disease mechanisms.
    Foster MH; Kelley VR
    Semin Nephrol; 1999 Mar; 19(2):173-81. PubMed ID: 10192250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies from long-lived 'memory' plasma cells of NZB/W mice drive immune complex nephritis.
    Cheng Q; Mumtaz IM; Khodadadi L; Radbruch A; Hoyer BF; Hiepe F
    Ann Rheum Dis; 2013 Dec; 72(12):2011-7. PubMed ID: 24114925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epistatic suppression of fatal autoimmunity in New Zealand black bicongenic mice.
    Loh C; Pau E; Lajoie G; Li TT; Baglaenko Y; Cheung YH; Chang NH; Wither JE
    J Immunol; 2011 May; 186(10):5845-53. PubMed ID: 21464090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.